PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,074,009 | +34.3% | 9,503,782 | +69.7% | 0.63% | +65.1% |
| Q2 2022 | $7,503,000 | -44.4% | 5,598,807 | -12.4% | 0.38% | -12.2% |
| Q1 2022 | $13,485,000 | -43.5% | 6,391,355 | -0.7% | 0.43% | -33.6% |
| Q4 2021 | $23,870,000 | -40.6% | 6,433,938 | -20.2% | 0.65% | -29.8% |
| Q3 2021 | $40,215,000 | -33.4% | 8,059,121 | -12.9% | 0.93% | -35.1% |
| Q2 2021 | $60,362,000 | -3.7% | 9,257,868 | +1.7% | 1.44% | -11.5% |
| Q1 2021 | $62,709,000 | -13.8% | 9,101,475 | +27.6% | 1.62% | -26.7% |
| Q4 2020 | $72,767,000 | +175.1% | 7,134,094 | -5.6% | 2.21% | +132.9% |
| Q3 2020 | $26,455,000 | -31.4% | 7,558,576 | -2.1% | 0.95% | -44.5% |
| Q2 2020 | $38,544,000 | +52.2% | 7,724,235 | +3.7% | 1.71% | +5.1% |
| Q1 2020 | $25,323,000 | – | 7,447,987 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |